Scientists have examined data from as many as 2.4 million people with diabetes to find out exactly what impact glucagon-like peptide 1 receptor agonists have on our health. These types of substances are the main component of medicines such as Ozempic and Mounjaro. They announced their results yesterday in the scientific journal Nature Medicine. HLN science journalist Martijn Peters explains the 42 health benefits and 19 disadvantages.
ttn-3
Finally, major research into the pros and cons of ‘miracle drugs’ like Ozempic: but how reliable is it?
Bytaketonews
Jan 21, 2025